Atlas Trials

Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer

Clinical trial NCT00028158 · COMPLETED

Trial details

NCT number
NCT00028158
Sponsor
MediGene
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
GliomaAstrocytomaGlioblastoma
Start date
2001-12-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.